Skip to main content
Clinical Trials/NCT02151630
NCT02151630UnknownPhase 2

Comparison of 70% Pyruvic Acid Solution and Duofilm Solution in Treatment of Plantar Wart

Isfahan University of Medical Sciences1 site in 1 country60 target enrollmentStarted: May 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Enrollment
60
Locations
1
Primary Endpoint
Wart number

Study Overview

Brief Summary

Plantar warts can be bothersome and painful requiring treatment. The investigators will compare the efficacy of pyruvic acid and salicylic acid in treating multiple plantar warts. Patients with multiple plantar warts will be randomized to receive either pyruvic acid 70% or compound salicylic acid solution (salicylic acid 16.7%, lactic acid 16.7%, and collodion 100%) applying topically twice a day for 4 weeks. Patients will be visited every 2 weeks for one month after starting treatment and then every one month for up to 3 months. The number and size of warts will be evaluated.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
12 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • aged 12 years and above
  • multiple warts (at least 2)

Exclusion Criteria

  • mosaic warts
  • already under any treatment for warts
  • pregnant or lactating women

Arms & Interventions

Pyruvic acid

Active Comparator

Patients will receive pyruvic acid solution 70% prepared by solving of pyruvic acid in water/ethanol solution. Patients will be advised to apply the solution twice daily for a period of four weeks. Application of petrolatum to the surrounding normal skin protects against the corrosive effect of the concentrated acid.

Intervention: Pyruvic acid (Drug)

Salicylic acid

Active Comparator

Patients will receive a combination of salicylic acid 16.7%, lactic acid 16.7%, and collodion 100%. Patients will be advised to apply the solution twice daily for a period of four weeks. Application of petrolatum to the surrounding normal skin protects against the corrosive effect of the concentrated acid.

Intervention: Salicylic Acid (Drug)

Outcomes

Primary Outcomes

Wart number

Time Frame: From before to 3 months after

Patients will be visited every two weeks for one month and then every month for up to 3 months by a dermatologist. On each visit, warts will be inspected to determine the number of warts. Any wart totally non-detectable by inspection and touch will be considered as healed.

Wart size

Time Frame: From before to 3 months after

Patients will be visited every two weeks for one month and then every month for up to 3 months by a dermatologist. On each visit, warts will be inspected to determine the size of warts. The size of the warts will be calculated as the mean size of all the warts.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fatima Assaf

Dr.

Isfahan University of Medical Sciences

Study Sites (1)

Loading locations...

Similar Trials

Pyruvic Acid Versus Salicylic Acid... | Clinical Trial